Your Label Here Blood Clotting First Aid Aerosol, Spray
NDC Package 52982-106-03
Package Information
Your Label Here Blood Clotting First Aid (benzethonium chloride and lidocaine) aerosols is shake can well before usingclean affected areaspray a small amount of this product on the area 1 to 3 times dailymay eb covered with a sterile bandageif bandaged, let dry firstadults and children 2 years of age and older: apply to affected area not more than 3 to 4 times dailychildren under 2 years of age: do not use, consult a doctor. This formulation utilizes a aerosol, spray delivery system. Marketed by Dixon Investments, Inc., this product is identified by NDC 52982-106 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 1545716 - benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray
- RxCUI: 1545716 - benzethonium chloride 2 MG/ML / lidocaine 40 MG/ML Topical Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52982 - Dixon Investments, Inc.
- 52982-106 - Your Label Here Blood Clotting First Aid
- 52982-106-03 - 85 g in 1 BOTTLE, SPRAY
- 52982-106 - Your Label Here Blood Clotting First Aid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52982-106-03 identifies a specific commercial package of 85 g in 1 bottle, spray of Your Label Here Blood Clotting First Aid, a human over the counter drug labeled by Dixon Investments, Inc.. This aerosol, spray is formulated for topical use and contains lidocaine; benzethonium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dixon Investments, Inc. on April 05, 2013.
How is this Dixon Investments, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52982010603. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.